|
Name |
1-(2,4-Dihydroxy-3,5-dimethylphenyl)ethanone
|
| Molecular Formula | C10H12O3 | |
| IUPAC Name* |
1-(2,4-dihydroxy-3,5-dimethylphenyl)ethanone
|
|
| SMILES |
CC1=CC(=C(C(=C1O)C)O)C(=O)C
|
|
| InChI |
InChI=1S/C10H12O3/c1-5-4-8(7(3)11)10(13)6(2)9(5)12/h4,12-13H,1-3H3
|
|
| InChIKey |
AMZNYVFIWCPUAY-UHFFFAOYSA-N
|
|
| Synonyms |
Clavatol; Clavatol (phenone); 1-(2,4-Dihydroxy-3,5-dimethylphenyl)ethanone; 577-45-7; NY65Z5RZ3T; Ethanone, 1-(2,4-dihydroxy-3,5-dimethylphenyl)-; 2',4'-dihydroxy-3',5'-dimethylacetophenone; 1-(2,4-dihydroxy-3,5-dimethylphenyl)ethan-1-one; UNII-NY65Z5RZ3T; Acetylphenone, 2',4'-dihydroxy-3',5'-dimethyl-; DTXSID30973293; CHEBI:188925; BS-1025; 1-(2,4-Dihydroxy-3,5-dimethyl-phenyl)-ethanone
|
|
| CAS | 577-45-7 | |
| PubChem CID | 3083634 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 180.2 | ALogp: | 2.2 |
| HBD: | 2 | HBA: | 3 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 57.5 | Aromatic Rings: | 1 |
| Heavy Atoms: | 13 | QED Weighted: | 0.653 |
| Caco-2 Permeability: | -4.709 | MDCK Permeability: | 0.00001530 |
| Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.007 |
| Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.186 |
| 30% Bioavailability (F30%): | 0.003 |
| Blood-Brain-Barrier Penetration (BBB): | 0.141 | Plasma Protein Binding (PPB): | 94.48% |
| Volume Distribution (VD): | 0.585 | Fu: | 4.59% |
| CYP1A2-inhibitor: | 0.795 | CYP1A2-substrate: | 0.941 |
| CYP2C19-inhibitor: | 0.145 | CYP2C19-substrate: | 0.371 |
| CYP2C9-inhibitor: | 0.156 | CYP2C9-substrate: | 0.429 |
| CYP2D6-inhibitor: | 0.101 | CYP2D6-substrate: | 0.35 |
| CYP3A4-inhibitor: | 0.04 | CYP3A4-substrate: | 0.245 |
| Clearance (CL): | 11.716 | Half-life (T1/2): | 0.868 |
| hERG Blockers: | 0.034 | Human Hepatotoxicity (H-HT): | 0.174 |
| Drug-inuced Liver Injury (DILI): | 0.155 | AMES Toxicity: | 0.029 |
| Rat Oral Acute Toxicity: | 0.231 | Maximum Recommended Daily Dose: | 0.628 |
| Skin Sensitization: | 0.904 | Carcinogencity: | 0.385 |
| Eye Corrosion: | 0.482 | Eye Irritation: | 0.936 |
| Respiratory Toxicity: | 0.149 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC004879 | ![]() |
0.674 | D0L5FY | ![]() |
0.264 | ||
| ENC001748 | ![]() |
0.592 | D05FTJ | ![]() |
0.258 | ||
| ENC004817 | ![]() |
0.509 | D09EBS | ![]() |
0.254 | ||
| ENC001360 | ![]() |
0.500 | D05QDC | ![]() |
0.244 | ||
| ENC001445 | ![]() |
0.467 | D0Y7PG | ![]() |
0.243 | ||
| ENC002336 | ![]() |
0.452 | D0C4YC | ![]() |
0.240 | ||
| ENC005230 | ![]() |
0.452 | D01WJL | ![]() |
0.240 | ||
| ENC002391 | ![]() |
0.447 | D0H2ZW | ![]() |
0.237 | ||
| ENC001359 | ![]() |
0.422 | D0JO3U | ![]() |
0.235 | ||
| ENC002528 | ![]() |
0.418 | D0FA2O | ![]() |
0.231 | ||